1. Home
  2. CYPH vs NDLS Comparison

CYPH vs NDLS Comparison

Compare CYPH & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

SELL

Current Price

$3.33

Market Cap

73.3M

Sector

Health Care

ML Signal

SELL

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$12.51

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
NDLS
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
68.7M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
CYPH
NDLS
Price
$3.33
$12.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 12.4M
32.1K
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.87
N/A
EPS
★ N/A
N/A
Revenue
$1,500,000.00
★ $495,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$408.92
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 0.37
52 Week Low
$0.49
$0.47
52 Week High
$4.19
$19.00

Technical Indicators

Market Signals
Indicator
CYPH
NDLS
Relative Strength Index (RSI) 57.30 39.71
Support Level $0.65 $10.71
Resistance Level $4.19 $15.07
Average True Range (ATR) 0.36 0.78
MACD -0.07 -0.01
Stochastic Oscillator 87.17 8.88

Price Performance

Historical Comparison
CYPH
NDLS

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

Share on Social Networks: